Hidradenitis Suppurativa Clinical Trials

What is Hidradenitis Suppurativa?

Hidradenitis suppurativa (HS), or acne inversa, is a chronic inflammatory condition characterized by painful, recurring lumps under the skin. These lesions typically develop in intertriginous zones—areas like the armpits, groin, and breasts where skin rubs together. Over time, these lumps can rupture, leading to abscesses, irreversible scarring, and the formation of "sinus tracts" or tunnels beneath the skin surface. HS often begins post-puberty and persists for decades, significantly impacting physical mobility and emotional health.

Demographically, women are three times more likely to be diagnosed than men. Additionally, Black individuals experience higher rates of HS, a disparity potentially linked to genetic predispositions. Effective management generally requires a multidisciplinary approach combining specialized wound care, long-term antibiotics, and surgical intervention to prevent progressive tissue damage.

Current HS clinical trials are investigating potential new hidradenitis suppurativa treatment options aimed at improving patient outcomes.

Enroll Now!

STUDY

Evaluation of an Investigational Treatment for Hidradenitis Suppurativa

Participating in clinical trials for hidradenitis suppurativa is a vital step toward discovering more potential ways to manage this chronic condition. This hidradenitis suppurativa research study focuses on a new investigational treatment designed to be applied directly to the skin. The primary purpose of this HS clinical trial is to evaluate the safety and effectiveness of this localized approach.

Researchers are investigating whether this targeted therapy can reduce the number of painful nodules and abscesses while minimizing the risk of side effects. By participating in these trials, patients contribute to medical advancements that may lead to faster healing and fewer recurrences. This study provides a unique opportunity for individuals to access potential new therapies under close medical supervision. It aims to determine if this investigational treatment can become a standard option for improving long-term skin health and quality of life.

Age
18 years or older

Location:
Arizona and Colorado

Status:
Recruiting

Condition
Hidradenitis suppurativa

What to Expect in a Hidradenitis Suppurativa Clinical Trials

If you choose to join a hidradenitis suppurativa clinical trials, your journey typically begins with a screening visit to confirm the study is a right fit for you. Once enrolled, you will receive study-related care according to the trial protocol.

Throughout the study, you can expect regular check-ups with medical professionals who will monitor your skin’s progress and your overall well-being. These visits are designed to track how the investigational treatment for hidradenitis suppurativa performs and to ensure your safety.

Your participation plays a direct role in helping researchers understand better ways to manage this condition for everyone.

Frequently Asked
Questions


  • No. If you qualify and choose to participate, all study-related care—including the investigational topical treatment and exams by specialists—is provided at no cost.

  • Yes. Your participation is entirely voluntary. You have the right to leave the clinical trial at any time, for any reason, without it affecting your future medical care. Your safety and comfort are always the top priority.

  • Adults aged 18 and older who have been diagnosed with hidradenitis suppurativa may qualify. Eligibility will be determined during a screening process that reviews specific health criteria.